UNH
UnitedHealth Group Incorporated
—
400.96 $
+1.4300 (%+0.36)
Previous Close: 399.53
Day Low₺399.253
Day High₺406.18
UNH: UnitedHealth Group Incorporated Financials
UNH Income Statement
Total revenue
Net income
Gross margin TTM
18.53%
Operating margin TTM
4.24%
Net profit margin TTM
2.69%
Return on investment TTM
—
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 447,567,000,000 | 400,278,000,000 | 371,622,000,000 | 324,162,000,000 |
| Operating income | 18,964,000,000 | 32,287,000,000 | 32,358,000,000 | 28,435,000,000 |
| Net income | 12,056,000,000 | 14,405,000,000 | 22,381,000,000 | 20,120,000,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 447,567,000,000 | 400,278,000,000 | 371,622,000,000 | 324,162,000,000 |
| Cost of revenue | 364,650,000,000 | 310,879,000,000 | 280,664,000,000 | 244,545,000,000 |
| Gross profit | 82,917,000,000 | 89,399,000,000 | 90,958,000,000 | 79,617,000,000 |
| Research and development expenses | 0 | 0 | 0 | 0 |
| General and administrative expenses | 0 | 0 | 0 | 0 |
| Selling and marketing expenses | 0 | 0 | 0 | 0 |
| Selling, general and administrative expenses | 0 | 0 | 0 | 0 |
| Other expenses | 63,953,000,000 | 57,112,000,000 | 58,600,000,000 | 51,182,000,000 |
| Operating expenses | 63,953,000,000 | 57,112,000,000 | 58,600,000,000 | 51,182,000,000 |
| Cost and expenses | 428,603,000,000 | 367,991,000,000 | 339,264,000,000 | 295,727,000,000 |
| Net interest income | -4,002,000,000 | -3,906,000,000 | -3,246,000,000 | -2,092,000,000 |
| Interest income | 0 | 0 | 0 | 0 |
| Interest expense | 4,002,000,000 | 3,906,000,000 | 3,246,000,000 | 2,092,000,000 |
| Depreciation and amortization | 4,361,000,000 | 4,099,000,000 | 3,972,000,000 | 3,400,000,000 |
| EBITDA | 23,060,000,000 | 28,076,000,000 | 36,330,000,000 | 31,835,000,000 |
| EBIT | 18,699,000,000 | 23,977,000,000 | 32,358,000,000 | 28,435,000,000 |
| Non-operating income (excl. interest) | 265,000,000 | 8,310,000,000 | 0 | 0 |
| Operating income | 18,964,000,000 | 32,287,000,000 | 32,358,000,000 | 28,435,000,000 |
| Total other income/expenses (net) | -4,267,000,000 | -12,216,000,000 | -3,246,000,000 | -2,092,000,000 |
| Income before tax | 14,697,000,000 | 20,071,000,000 | 29,112,000,000 | 26,343,000,000 |
| Income tax expense | 1,890,000,000 | 4,829,000,000 | 5,968,000,000 | 5,704,000,000 |
| Net income from continuing operations | 12,807,000,000 | 15,242,000,000 | 23,144,000,000 | 20,639,000,000 |
| Net income from discontinued operations | 0 | 0 | 0 | 0 |
| Other adjustments to net income | 0 | 0 | 0 | 0 |
| Net income | 12,056,000,000 | 14,405,000,000 | 22,381,000,000 | 20,120,000,000 |
| Net income deductions | 0 | 0 | 0 | 0 |
| Bottom line net income | 12,056,000,000 | 14,405,000,000 | 22,381,000,000 | 20,120,000,000 |
| EPS | 13 | 16 | 24 | 22 |
| Diluted EPS | 13 | 16 | 24 | 21 |
| Weighted average shares outstanding | 910,000,000 | 929,000,000 | 928,000,000 | 934,000,000 |
| Weighted average diluted shares outstanding | 910,000,000 | 929,000,000 | 938,000,000 | 950,000,000 |